𝔖 Bobbio Scriptorium
✦   LIBER   ✦

lontophoretic Delivery of Apomorphine II: An In Vivo Study in Patients with Parkinson's Disease

✍ Scribed by Ronald van der Geest; Teus van Laar; Josy M. Gubbens-Stibbe; Harry E. Boddé; Meindert Danhof

Book ID
110309224
Publisher
Springer US
Year
1997
Tongue
English
Weight
657 KB
Volume
14
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new sublingual formulation of apomorph
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
✍ Dr. T. van Laar; C. Neef; M. Danhof; K. I. Roon; R. A. C. Roos 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

## Abstract A new formulation of a sublingual tablet with 10 mg apomorphine was examined in 13 patients with Parkinson's disease. Vitamin C (250 mg) was added sublingually to lower the salivary pH. Four patients received sublingual apomorphine and nine received sublingual apomorphine as well as vit

Pharmacokinetics and clinical efficacy o
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: A study of five different suppositories
✍ Dr. T. van Laar; E. N. H. Jansen; C. Neef; M. Danhof; R. A. C. Roos 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

## Abstract The pharmacokinetics and clinical effects of apomorphine after rectal administration were determined in five patients with idiopathic Parkinson's disease (PD). Three different pharmaceutical formulations were tested: a rectal solution of apomorphine (10 or 15 mg), a gelatin suppository